Condition
Grafting, Kidney
Total Trials
2
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Fk778
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Phase 2 (1)
Phase 4 (1)
Trial Status
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Fk7781
- Tacrolimus1
Active Sponsors
- Astellas Pharma Inc1
- Veloxis Pharmaceuticals1
- Astellas Pharma Europe B.V.1
- University of California, Los Angeles1
Top Investigators
Universitätsklinik Charité
University of California, Los Angeles
Related Conditions
- Kidney Transplantation2
- Renal Transplantation2
- Transplantation Renal1
- Transplantation Kidney1